These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 39273576)

  • 1. The Molecular and Immunological Landscape of Meningiomas.
    Lotsch C; Warta R; Herold-Mende C
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving concepts in meningioma management in the era of genomics.
    Hsieh AL; Bi WL; Ramesh V; Brastianos PK; Plotkin SR
    Cancer; 2024 Aug; 130(15):2586-2600. PubMed ID: 38753473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Related mechanisms, current treatments, and new perspectives in meningioma.
    Inetas-Yengin G; Bayrak OF
    Genes Chromosomes Cancer; 2024 May; 63(5):e23248. PubMed ID: 38801095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningiomas: Overview and New Directions in Therapy.
    Wang N; Osswald M
    Semin Neurol; 2018 Feb; 38(1):112-120. PubMed ID: 29548058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of immune infiltration and its relevance to survival outcome in meningiomas.
    Chen X; Tian F; Lun P; Feng Y
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32378707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current immunotherapy techniques in meningioma.
    White AJ; Harary M; Casaos J; Everson RG
    Expert Rev Anticancer Ther; 2024 Oct; 24(10):931-941. PubMed ID: 39233324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
    Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.
    Wang JZ; Landry AP; Raleigh DR; Sahm F; Walsh KM; Goldbrunner R; Yefet LS; Tonn JC; Gui C; Ostrom QT; Barnholtz-Sloan J; Perry A; Ellenbogen Y; Hanemann CO; Jungwirth G; Jenkinson MD; Tabatabai G; Mathiesen TI; McDermott MW; Tatagiba M; la Fougère C; Maas SLN; Galldiks N; Albert NL; Brastianos PK; Ehret F; Minniti G; Lamszus K; Ricklefs FL; Schittenhelm J; Drummond KJ; Dunn IF; Pathmanaban ON; Cohen-Gadol AA; Sulman EP; Tabouret E; Le Rhun E; Mawrin C; Moliterno J; Weller M; Bi WL; Gao A; Yip S; Niyazi M; ; Aldape K; Wen PY; Short S; Preusser M; Nassiri F; Zadeh G
    Neuro Oncol; 2024 Oct; 26(10):1742-1780. PubMed ID: 38695575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment options for meningioma.
    Apra C; Peyre M; Kalamarides M
    Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic landscape of intracranial meningiomas.
    Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
    J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations in meningioma: prognostic and therapeutic perspectives.
    Birzu C; Peyre M; Sahm F
    Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
    Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
    Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningiomas in 2009: controversies and future challenges.
    Campbell BA; Jhamb A; Maguire JA; Toyota B; Ma R
    Am J Clin Oncol; 2009 Feb; 32(1):73-85. PubMed ID: 19194129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MOLECULAR PATHOLOGY OF MENINGIOMAS].
    Murnyák B; Csonka T; Hortobágyi T
    Ideggyogy Sz; 2015 Sep; 68(9-10):292-300. PubMed ID: 26665490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningioma: an update.
    Lusis E; Gutmann DH
    Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas.
    Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE
    Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options.
    Qin C; Huang M; Pan Y; Li Y; Long W; Liu Q
    Brain Tumor Pathol; 2021 Jul; 38(3):156-172. PubMed ID: 33903981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas.
    Cordova C; Kurz SC
    Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.
    Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
    Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of benign and aggressive intracranial meningiomas.
    Akeyson EW; McCutcheon IE
    Oncology (Williston Park); 1996 May; 10(5):747-56; discussion 756-9. PubMed ID: 8738830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.